Study shows benefit of shunt in cirrhosis

10/18/2013 | Healio (free registration)

In a study presented at the American College of Gastroenterology meeting, placement of a transjugular portosystemic shunt led to complete portal vein recanalization among 68% of cirrhotic participants with portal vein thrombosis and significant improvement among another 20%, as measured with Doppler vascular ultrasound. "This study has brought up new ideas in the field of PVT treatment," said researcher Modaresi Esfeh.

View Full Article in:

Healio (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA